Recognizing and treating Lyme disease

Scott J Saccomano1, Debra A Hrelic

  • 1Scott J. Saccomano is an assistant professor in the College of Health and Human Services at the University of North Carolina, Wilmington, N.C. Debra A. Hrelic is the academic program coordinator for the University of North Carolina, Wilmington, in Wilmington, N.C.

Insights

Posttreatment Lyme disease syndrome can cause long-term disability and significant healthcare costs, even after initial antibiotic treatment for Lyme disease. This condition impacts patients physically and mentally.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Medicine

Background:

  • Lyme disease is the most frequently reported vector-borne illness in the U.S.
  • Persistent symptoms after treatment can lead to substantial long-term healthcare expenses.
  • Posttreatment Lyme disease syndrome (PLDS) results in chronic, disabling symptoms.

Purpose of the Study:

  • To summarize the impact of Posttreatment Lyme disease syndrome.
  • To highlight the chronic nature and disabling effects of PLDS.
  • To underscore the economic burden associated with persistent Lyme disease symptoms.

Main Methods:

  • Literature review of existing studies on Lyme disease and PLDS.
  • Analysis of reported symptoms and patient outcomes.
  • Examination of healthcare cost data related to chronic vector-borne diseases.

Main Results:

  • PLDS is characterized by diverse chronic symptoms affecting physical and mental health.
  • Patients with PLDS may experience prolonged disability.
  • The economic impact of managing persistent symptoms is considerable.

Conclusions:

  • Posttreatment Lyme disease syndrome presents a significant challenge due to its chronic and disabling nature.
  • Effective management strategies are needed to mitigate the long-term health and economic consequences of PLDS.
  • Further research is warranted to understand and treat persistent symptoms following Lyme disease.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.4K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.3K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
966
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
563